Predictive Technology Group IncOver The Counter Market:PRED
- LAST PRICE0.0003
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 0.0003
- Day Range---
- 52 Week Range
- Volume2
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Predictive Technology Group Inc | 89.9K | 0.0x | --- |
Codiak BioSciences, Inc. | 405.1K | 0.0x | --- |
Exicure Inc | 7.1M | -0.8x | --- |
SQZ Biotechnologies Co | 16.9M | -0.2x | --- |
Response Genetics Inc | 40.0 | 0.0x | --- |
Viaderma Inc | 11.4M | 0.0x | --- |
Company Information
Predictive Technology Group, Inc. develops, commercializes discoveries and technologies involved in novel molecular diagnostic, therapeutic, and Human Cellular and Tissue-Based Products (HCT/Ps). The Company operates through two segments: Human Cell and Tissues Products (HCT/Ps) and diagnostics and therapeutics. The HCT/P segment offers minimally manipulated tissue products intended for homologous use, prepared utilizing extraction methods that reduce the loss of important scaffolding, growth factors and cytokines. The Company's Diagnostics and Therapeutics segment uses data analytics for disease identification and subsequent therapeutic intervention through novel gene-based diagnostics, and companion therapeutics. It offers genetic tests through a number of Advanced Reproductive Technologies (ART) clinics.The Company’s tests include ARTguide and FertilityDX. The RTguide test is a genetic test for women experiencing infertility and other genetic condition.
Contact Information
- Headquarters
- 615 ARAPEEN DRIVE, SUITE 300SALT LAKE CITY, UT, United States 84108
- Phone
- 757-306-6090
- Fax
- ---
Executives
- Independent Chairman of the Board
- John Sorrentino
- President, Chief Executive Officer, Interim Chief Financial Officer, Director
- Bradley Robinson
- CEO of Predictive Therapeutics, Director
- Michael Dey
- Chief Operating Officer
- Paul Evans
- Executive Vice President Predictive Technology Group, Inc, Founder, Chief Executive Officer – Predictive Biotech, Inc.
- Eric Olson
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $89.9K |
|---|---|
Revenue (TTM) | $19.2M |
Shares Outstanding | 299.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.91 |
EPS | $-0.24 |
Book Value | $0.18 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -224.32% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
